Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma.

A correction to this paper has been published and can be accessed via a link at the top of the paper.

Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma.

Recent genomic research efforts in multiple myeloma have revealed clinically relevant molecular subgroups beyond conventional cytogenetic classifications. Implementing these advances in clinical trial design and in routine patient care requires a new generation of molecular diagnostic tools. Here, we present a custom capture next-generation sequencing (NGS) panel designed to identify rearrangements involving the IGH locus, arm level, and focal copy number aberrations, as well as frequently mutated genes in multiple myeloma in a single assay.